Launching the Alzheimer’s Disease Atlas at ADI2026 Conference
On 15 April, at the ADI Conference in Lyon, France, ADI shared the Alzheimer’s Disease Atlas, a first-of-its-kind website mapping the global landscape of Alzheimer’s disease.
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
On 15 April, at the ADI Conference in Lyon, France, ADI shared the Alzheimer’s Disease Atlas, a first-of-its-kind website mapping the global landscape of Alzheimer’s disease.
Read the transcript of ADI CEO Paola Barbarino's full speech at the French Ministry of Health, in Paris, France, 10 April 2026.
As 2021 comes to an end, ADI CEO Paola Barbarino reflects on the work of ADI in 2021 and what we are looking towards to in 2022.
The Dementia Alliance International (DAI) Environmental Design Special Interest Group (ED-SiG) is a newly established international advocacy group calling for implementations of designs that respect the dignity, autonomy, independence and equality of opportunity for people living with dementia.
To date, only 37 of 194 countries that signed up to implement the WHO Global action plan on dementia have created and funded national dementia plans. Our new campaign aims to galvanise and encourage more governments to develop national dementia plans following their 2017 commitment.
Earlier this year, Alzheimer’s Disease Association of the Philippines partnered with Memory Lane Games to build a culturally relevant and customised cognitive game app for carers and people living with dementia in the Philippines.
ADI hosted its first virtual regional meeting for ADI members in Latin America, since the COVID-19 pandemic began, on 12 November. The second virtual regional meeting Asia Pacific took place a week later on 12 November. During the Latin America meeting, 18 participants from 13 countries were in attendance. The 2-hour meeting…
The 'Building an inclusivity society' campaign from ADI member France Alzheimer aims to raise awareness amongst civil society and to dismantle stigmatic attitudes and ideas around dementia.
The news follows a negative vote trend by the Committee for Medicinal Products for Human Use (CHMP) at their oral explanation meeting.
In this blog, the co-leaders of the Brain Health Diplomacy Working Group from The Global Brain Health Institute (GBHI), write about the necessity for brain health diplomacy in advancing better brain health.